The pharmacy and health care provider dropped nine spots on the list this year, as demand for services related to COVID—including vaccines, testing, and treatment—dropped sharply. But profits rose by 70%, to $4.3 billion, in the company’s second full year under CEO Rosalind “Roz” Brewer.
  • In its continuing efforts to expand into health care services, Walgreens announced in October 2022 that it would acquire in full home-health-care company CareCentrix, purchasing the remaining 45% stake.
  • Like other health care companies, Walgreens has faced intense scrutiny for its alleged role in the opioid crisis. Under a settlement announced in December 2022, Walgreens will pay state and local governments up to $5.5 billion over 15 years to resolve lawsuits that accused its pharmacies of overprescribing opioids. (The company did not admit wrongdoing.)
  • In March 2023, Walgreens announced that it would not fill prescriptions for mifepristone, a drug commonly used in medical abortions, in states where lawmakers were threatening legal action against use of the drug. That decision drew angry responses from pro-choice lawmakers and activists.
Jeffrey Greenberg—UCG/Universal Images Group/Getty Images

Company Information

As of 6/5/23
Country
U.S.
Headquarters
Deerfield, Ill.
Industry
Food and Drug Stores
CEO
Roz Brewer
Company Type
Public
Ticker
WBA
Revenues ($M)
$132,703
Profits ($M)
$4,337
Market Value ($M)
$29,836
Employees
262,500
Figures are for fiscal year ended Aug. 31, 2022. Market value as of March 31, 2023.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$132,703
-10.7%
Profits ($M)
$4,337
70.6%
Assets ($M)
$90,124
-
Total Stockholder Equity ($M)
$25,275
-

Profit Ratios

Profit as % of Revenues
3.3%
Profits as % of Assets
4.8%
Profits as % of Stockholder Equity
17.2%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
5.01
EPS % Change (from 2021)
71%
EPS % Change (5 year annual rate)
5.8%
EPS % Change (10 year annual rate)
7.5%

Total Return

Total Return to Investors (2022)
-25%
Total Return to Investors (5 year, annualized)
-9.2%
Total Return to Investors (10 year, annualized)
2.9%

Walgreens Boots Alliance Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2022$148,5796.5%$2,542457.5%$81,285$23,419
2021$139,5372%$456-88.5%$87,174$20,637
2020$136,8664.1%$3,982-20.7%$67,598$23,512
2019$131,53711.3%$5,02423.2%$68,124$26,007
2018$118,2140.7%$4,078-2.3%$66,009$27,466
SHOW MORE
FortuneFortuneAnalytics tout
Lists ranking Walgreens Boots Alliance
RANK100000
World's Most Admired Companies - 2023The 25th Fortune World’s Most Admired Companies li...READ MORE
RANK27
Fortune 500 - 2023The Fortune 500, in its 69th year in 2023, ranks t...READ MORE
RANK45
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE
RANK10
Fortune Modern Board 25 - 2023Fortune collaborated with the Diligent Institute t...READ MORE